About
Dr
MohammadAli Sahebalzamani
Postdoctoral Researcher
DCU
Dr. MohammadAli Sahebalzamani is a Postdoctoral Researcher at I-Form, based at Dublin City University (DCU), specialising in biomedical materials. His expertise spans tissue engineering, biomaterials characterisation, scaffold fabrication, and data analysis.
He earned his PhD in Biomedical Engineering from DCU, supported by the Irish Research Council Government of Ireland Postgraduate Scholarship (IRC-GOIPG). His doctoral research focused on the fabrication of multifunctional nanocomposite coatings using Layer-by-Layer assembly on highly porous materials for bone tissue engineering. Throughout his PhD, Dr. Sahebalzamani developed deep expertise in in customising and optimising both surface and bulk properties of tissue-engineered scaffolds. His work centred on the design of mechanically robust, multifunctional multilayer nanocomposite coatings highly porous 3D porous scaffolds, aiming to enhance their in vivo performance in bone defect repair.
Dr. Sahebalzamani has authored more than 20 peer-reviewed journal publications and one book chapter, and has delivered over 10 research presentations at national and international conferences in the fields of biomaterials and biomedical engineering. His current research is focused on the translational product development of bone scaffolds, with the goal of advancing these technologies from the research phase through to clinical application and eventual market introduction.
Technical Summary
At DCU, Dr. MohammadAli Sahebalzamani is working on a high-impact, cross-functional research project in collaboration with the I-Form Advanced Manufacturing Centre, Biodesign Europe Institute, and PBC Biomed. His postdoctoral research is focused on the development and clinical translation of a next-generation, vascularisation-promoting scaffold for bone repair—engineered to stimulate new bone formation while preventing avascular necrosis (AVN). This project combines cutting-edge tissue engineering strategies with advanced manufacturing technologies, with the overarching goal of advancing scaffold technology from bench to bedside.
A critical determinant of successful fracture repair is the formation of a vascular network within the scaffold, as the absence of adequate blood supply can result in AVN and the subsequent death of bone tissue. By replicating the physiological processes involved in natural bone healing, this project aims to address this challenge through the strategic design of a bioactive scaffold. Dr. Sahebalzamani's work involves optimising scaffold design and manufacture to meet clinical requirements, while assessing its biocompatibility and osteogenic properties through both in vitro and in vivo evaluations.
Dr. Sahebalzamani thrives in multidisciplinary environments where science, engineering, and clinical insight converge to deliver impactful medical device innovations. With over a decade of academic research experience in biomedical engineering and biomaterials science, and more than six years of hands-on expertise in the orthopaedic industry and clinical research, he is positioned to bridge the gap between scientific discovery and clinical translation.